What is Biosero?
Biosero is recognized as a leader in the laboratory automation sector, offering a comprehensive suite of integrated software and robotics solutions. Their flagship products, the Green Button Go Scheduler and Orchestrator, are instrumental in enabling scientists to automate complex processes and manage laboratory workflows with enhanced efficiency. These solutions cater to a diverse range of applications, including critical areas such as diagnostics, genomics, and drug discovery. By focusing on increasing productivity and fostering adaptability, Biosero has successfully supported over 1,000 laboratories globally, including all major pharmaceutical companies, solidifying its position as a key enabler of scientific research through its unified automation platform.
How much funding has Biosero raised?
Biosero has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Biosero
PPP
Public-Private Partnership
What's next for Biosero?
The substantial capital infusion, characterized as a large-scale late-stage funding event, positions Biosero for accelerated growth and market expansion. This strategic backing is expected to fuel further development of their innovative automation platform, potentially enabling the company to deepen its penetration in existing markets and explore new application areas. The company's focus on empowering scientific research through enhanced laboratory efficiency suggests a trajectory aimed at becoming an indispensable partner for research institutions and biopharmaceutical firms worldwide.
See full Biosero company page
